OI~/I~CrlI/E: To determine whether a computer-assisted reminder would alter prescribing habits for the treatment of hypertension in accordance with current clinical guidelines in a general internal medicine clinic.
D
rug prescribing is a major part of the practice of medicine, yet few randomized, controlled trials examining the effects of interventions have been aimed at improving physician drug prescribing habits in the pri mary care setting. Trials have failed to show an impact of printed materials and guidelines alone. 1-~ Educational outreach, in the form of face to face training, often re ferred to as "academic detailing." has been shown to be effective in changing drug prescribing habits, but suffers from an effect decay over time and a relatively high cost due to time and labor requirements, 1,~ Several studies have demonstrated that individualized, compute~generated feedback can influence prescribing patterns, e-7 Generat ing individual feedback can be time-intensive, thereby limiting practical application. Integrated hospital data management systems make it possible to automate some individualized feedback, with minimal cost and time requirements beyond the establishment of the program.
The Fifth Report of the Joint National Committee on
Detection. Evaluation and Treatment of High Blood Pressure (JNC V) has recommended ~ blockers and diuretics as first line therapy in the treatment of uncomplicated hypertension, on the basis of evidence that these drugs can reduce morbidity and mortality. ~ More than 80% of patients with essential hypertension can be treated effec tively with I~ blockers, diuretics, or a combination of the two. ' -~ Despite recommendations that they be used only in special clinical circumstances, calcium channel blockers (CCBs) are widely used as first-line therapy for the treatment of essential hypertension. Between 1982 and 1993, the percentage of hypertensive patients treated with CCBs increased from 0.3% to 270/o. in Unlike I~ blockers mid diuretics, there is no evidence that CCBs decrease the mor tality or morbidity of hypertension related disease. There are epidemiologic data. 11,1~ and some prospective data. is to suggest that some types of CCBs may increase cardio vascular risk in some populations. An intervention de signed to increase the use of first line agents, while decreasing the use of CCBs, would result in neutral or improved clinical outcomes, potentially at a lower cost.
Because of concern about the growing usage of CCBs at our institution, we sought to develop a mechanism to encourage primary care providers in our outpatient clin ics to prescribe I~ blockers and diuretics for the treatment of hypertension. We conducted a randomized, controlled trial to test the hypothesis that a guideline reminder, added to the patient chart at the time of the clinic visit. targeted using an automated computer program, could influence provider prescribing toward recommendations by the JNC V,
METHODS

Study Subjects
The trial was conducted at the General Internal MedP cine Clinic of the Veterans Aflhirs (VA) Puget Sound Health Care System. Seattle (Wash.) Division. between March mid August 1996. The study subjects were all of the 71 full time and part time primary care providers, i.e., staff phy sicimls, nurse practitioners, fellows, and residents, who saw patients in the clinic during the 6 month study pe riod. Approximately 5,500 patients were enrolled in the clinic at the time of the study, and more than 20,000 visits were made to the clinic in 1995. In 1995, staff physi clans provided 43% of all nonpsychiatric visits: residents and fellows. 41%: and nurse practitioners, 16%,
Study Design
A randomized, controlled design was used, A random number generator was used to randomize providers to ei ther the intervention or the control group, stratified ac cording to whether they were staff physicians, nurse practitioners, or residents or fellows. Providers were assigned numeric codes: study investigators were blinded to the coding identifiers,
Data Collection
The Seattle VA Medical Center maintains eomprehen sire patient information on a mainframe computer system called the Decentralized Hospital Computer Program (DHCP). Information on patient demographics, comorbid ity as assessed by inpatient ICD-9 codes and outpatient diagnosis codes, visit dates, medication profile, and labo ratory utilization was obtained from this database. A sep arate database maintaining pilot data for another ongoing study, the Ambulatory Care Quality Improvement Project (ACQUIP),14 was used to follow blood pressure (BP) and weight. Demographic and practice information on providers was obtained from the hospital Medical Staff Office.
Intervention
The intervention was designed to act at the point of patient contact during the clinic visit. It was targeted at the providers for patients receiving CCBs for hypertension. These patients were identified using a DHCP-based computer program that identified all patients being seen in the General Internal Medicine Clinic on the designated study day who had a prescription for a CCB written or refilled in the past 26 weeks, without having a nitrate prescription written or refilled during the same period. Nitrates were used as a proxy for active ischemic heart disease: eliminating all patients concurrently treated with nitrates and CCBs was expected to eliminate most patients receiving CCBs for mlgina. Because the pharmacy database records only prescriptions and refills, and cannot guarantee that medications listed are being taken as prescribed, we identified patients with prescriptions filled within 26 weeks of the visit data.
For each clinic visit, for each eligible patient, providers in the intervention group had a 1-page guideline reminder (Appendkx A) placed in the patient chart by the clinic pharmacist, attached to the medication refill forms that are given to providers at every patient visit, Providers in the control group received no reminder. The reminder highlighted the prescription and offered alternative drugs and doses. For continued CCB use, the reminder also asked the provider to designate one of four indications: prescription for a diagnosis other than hypertension, concurrent angina and hypertension, failure of other medications to control hypertension, or adverse effects from other medications for hypertension, The reminder was collected by the ward clerk when the patient checked out of clinic, and returned to the study investigators. Re sponse rate by visit for the completion and return of the guideline reminder was 72%. ranging from a return rate of 61% for nurse practitioners to 80% for staff physicians. Drug chmlges were recorded for the intervention group when the provider indicated a chmlge on the returned guideline reminder. The pharmacy computer data base was reviewed for every patient seen in both the intervention and control groups during the study period. Charts were reviewed for all patients with a drug change to confirm provider intent and medication changes,
The intervention was conducted between March and August 1996. Follow up to test for persistence of changes was continued through February 1997, The project was approved by the University of Washington Human Sub Jects Review Committee.
Statistical Analysis
The unit of analysis was the individual provider. Analysis was performed using SPSS for Windows, version 6.0.
Continuous variables were analyzed using Student's t test. Because of unequal variances due to different numbers of observations per subject, a randomization test was used to test for significance in rates of change, 15 with results reported for p values <,05, Rmldomization testing, also called permutation testing, is used to test the generic null hypothesis that one variable (randomization group) is un related to another (therapy changes), Significance is assessed by shuffling one variable relative to the other. If the variables are related, then the value of the original test statistic of unshuffled data should be extreme relative to the values obtained from shuffling. In this case, the ob served statistic was more extreme than any of the 5,000 rmldom samples generated from the data.
Further testing was done weighting by the number of 
RESU LTS Study Population at Baseline
The baseline characteristics of providers in the control and intervention groups were not substantially differ ent ( Table 1 ). The majority were board certified internists or residents or fellows in internal medicine, with fewer nurse practitioners.
Control and intervention patients were similar in age, gender, and initial BP, Consistent with other VA populations, the patient population for this study consisted pri marily of elderly males of European descent, with fewer At the initiation of the study, more patients in the in tervention group than patients in the control group were receiving a ~ blocker or an angiotensin-converting enzyme (ACE) inhibitor. Approximately 5% of patients in both groups had past, but not active, prescriptions for CCBs. Control and intervention groups had no significant difference in the type of CCB prescribed at the initiation of the study (Table 2) . Outpatient diagnostic codes, available for 87% of patients, showed no significant differences be tween the control and intervention groups (Figure 1 ).
Prescription Changes
Thirty nine of 346 patients were changed from CCBs to other antihypertensive medications (Table 3) . For another 6 patients, providers indicated that changes to med ications had been made, but no change could be docu mented by review of either pharmacy records or patient charts. In 5 patients the change in therapy was later re versed: 2 had inadequate BP control, 1 was changed by the primary provider but had CCBs renewed during an emergency department visit: 1 was changed by the pri mary provider but had a CCB added by a neurology con sultmK, and 1 had increasing dyspnea on exertion.
Data on drug indications were available for 181 of 307 patients maintained on CCBs (Table 4) . Of the pa tients not changed, 23% listed that CCBs were prescribed for angina, 48 (14%) indicated that the patient had failed blockers or diuretics, 48 (14%) indicated that the patient We demonstrated a significant effect on dru~prescribing habits in a general internal medicine clinic through the use of a simple computerized reminder system. This intervention resulted in 11.3% of intervention patients being changed to first-line antihypertensive agents, without change in control of their hypertension. We believe that this change rate is actually conservative, as the computer program misclassified 23% of patients who were prescribed these drugs for angina, By extending the exclusion for patients on nitrates to 2 years, another 66 pm tients (19.1%) would have been excluded from the study, None of these patients had their medications changed, Using these criteria, 14% of patients had their medicm tions changed to first-line agents. Excluding patients that had any provider-reported contraindication. 23.6% of patients seen by intervention providers had therapy altered.
m i d 33 (10%) i n d i c a t e d t h a t C C B s were p r e s c r i b e d for i n d i c a t i o n s o t h e r t h a n h y p e r t e n s i o n . In addition, t h e following c o n t r a i n d i c a t i o n s for 6 b l o c k e r t h e r a p y were noted: 18 (10%) i n d i c a t e d c h r o n i c o b s t r u c t i v e p u l m o n a r y d i s e a s e (COPD) or b r o n c h o s p a s m . 2 4 (13%) i n d i c a t e d d i a b e t e s mellitus, a n d 6 (3%) i n d i c a t e d a h i s t o r y of d e p r e s s i o n .
O t h e r Utilization
To evaluate the i m p a c t of t h i s i n t e r v e n t i o n o n n o np h a r m a c y resources, we e x a m i n e d the follow u p BP, clinic visits, l a b o r a t o r y tests, a n d a d m i s s i o n s a c c o r d i n g to group, a n d to w h e t h e r d r u g t h e r a p y w a s c h a n g e d , for the 6 m o n t h s following the i n t e r v e n t i o n (Table 5). In c o m p a r i s o n with c o n t r o l patients, p a t i e n t s w h o s e m e d i c a t i o n t h e r a p y w a s c h a n g e d s h o w e d no clinically significant c h a n g e in BP a n d no significant difference in the n u m b e r of l a b o r a t o r y t e s t s ordered, follow u p visits, or h o s p i t a l a d m i s s i o n s .
D I S C U S S I O N C u l T e n t t h e r a p e u t i c g u i d e l i n e s are b a s e d o n r a n d o mized. controlled clinical trials s h o w i n g t h a t I~ b l o c k e r s a n d
We also note that. at baseline, a larger number of patients in the intervention group were already on 6 blockers and ACE inhibitors, biasing the study against finding a significmlt effect of the intervention and making regression toward the mean an unlikely explanation of the findings. This study population included many patients with comorbid conditions, such as diabetes mellitus, hyperlipidemia. COPD. and benign prostatic hyperplasia, that might also bias providers against the use of either [~ blockers or diuretics, In other, healthier populations the rate of change might be expected to be higher because there would be fewer relative contraindications for the use of blockers and diuretics, This study also provides information on the reasons CCBs are used in a VA outpatient setting. Almost one quarter of patients were reported to have both hypertension and angina. In almost 10% of patients, CCBs were used for indications other than hypertension or angina.
with chronic headache and alThythmias accounting for most of these cases. Finally, by report of their physicians, almost 25% of patients either failed to obtain adequate BP control or had unacceptable adverse effects using I~ blockers or diuretics, suggesting failure rates for first line tiler apy that are higher than reported in larger drug trials, Our findings are consistent with past studies in demonstrating that an intervention can change provider pre scribing behavior if it is individually targeted and delivered at the point of patient contact. It differs from past studies in showing that successful interventions need not be labor-intensive, as with academic detailing, but rather cml rely on computer case finding to identify potentially modifiable prescribing patterns. The ability to design and implement an intervention that changes utilization without requiring extensive infrastructure or personnel makes it particularly attractive.
Though this trial was not designed for a formal cost analysis, we can make crude estimates of the cost of the study and the potential cost savings from drug changes.
The computer program was developed in approximately 18 hours of programmer time. which would cost approximately $460. Each study day required approximately 10 minutes of time by the pharmacist to place the study insert in the patient chart, This time totals 16 hours over the 20 week study period, which would cost approxi mately 8400, The total of direct costs was therefore less than 81.000, The total cost savings, calculated by subtracting the cost of the substituted drug from the previ ously prescribed CCB. was $7.140 for the 6-month period following the study, There was no evidence that providers ordered more laboratory tests or that patients had greater clinic utilization after their medications were chmlged, Full cost studies have shown that I~ blockers and diuretics are less expensive than CCBs for the treatment of hy pertension, even when the costs of additional follow-up. Third, this trial was not designed to test for persis tence of effect, In most settings, interventions that change provider behavior show decay of intervention effect over time. Although we were able to show that providers were willing to change prescribing habits when prompted at the patient visit level, it is not clear whether this interven tion actually changed long-term prescribing habits.
Finally. this trial was conducted in an academic setting. Providers in this setting may be more inclined to consider altering their practice style, particularly when prompted by a colleague, Though this effect cannot be ruled out, providers knew that the investigators were blinded to their identities throughout the trial. Providers in this setting may also be more influenced by recent negative literature on CCBs, though this effect would be seen in both control and intervention providers, Our study shows that it is possible to use a simple. inexpensive, nonthreatening, computer driven interven tion to encourage treatment of hypertension in accordmlce with current recommendations, Similar interventions in other areas offer the potential to improve patient care with minimal implementation costs, When treatment according to guidelines can be cost-saving, as with hypertension, such programs could reach the elusive goal of si multmmously improving care while decreasing total health care costs.
